Daily FNArena News - Australia

Weekly Update on ASX-listed companies buying in their own stock.

Westpac will focus on customer service and productivity going forward. Brokers welcome the extra clarity on the outlook but suspect some of the goals may be tough to achieve.

Gold projects remain hotly contested in Australia, whether it be via takeover, joint venture or further exploration. Two companies at different stages of growth provoke broker interest.

Further negative news has been forthcoming from ResMed’s SERVE-HF trial which has disappointed brokers.

Weekly update on recommendation, target price, and earnings forecast changes.

Brokers came away from CSR’s investor briefing confident in the outlook for building materials and the company’s position at the forefront of innovation.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Myer has unveiled its new look. Brokers like the revamped strategy but caution improvements are likely to be slow coming and there are risks.

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.